EMGS reports fourth quarter 2025 results

Electromagnetic Geoservices ASA’s (“EMGS” or the “Company”) financial report for the fourth quarter of 2025 is attached.

Summary:

* The Company recorded revenues of USD 3.9 million, down from USD 9.7 million in the fourth quarter of 2024.

* Adjusted EBITDA (including capitalised multi-client expenses and vessel and office lease expenses) of negative USD 1.3 million, down from USD 7.9 million in the fourth quarter of 2024.

* EMGS impaired USD 3.9 million in long-term assets and USD 2.7 million in inventory in the fourth quarter

* The Company continues to evaluate restoring operational capacity and securing future project opportunities, as well as potential strategic alternatives, including potential transactions for the sale of the Company’s assets and/or a partial or complete conversion of the convertible bonds under EMGS03.

Contact
Anders Eimstad, Chief Financial Officer, +47 94 82 58 36

About EMGS
EMGS, the marine EM market leader, uses its proprietary electromagnetic (EM) technology to support oil and gas companies in their search for offshore hydrocarbons. EMGS supports each stage in the workflow, from survey design and data acquisition to processing and interpretation. The Company's services enable the integration of EM data with seismic and other geophysical and geological information to give explorationists a clearer and more complete understanding of the subsurface. This improves exploration efficiency and reduces risks and the finding costs per barrel. CSEM technology can also be used to detect the presence of marine mineral deposits (primarily Seabed Massive Sulphides) and EMGS believes that the technology can also be used to estimate the mineral content of such deposits. The Company is undertaking early-stage initiatives to position itself in this future market.

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Attachment

• EMGS Q4 2025 Report

You May Also Be Interested In

• BioAdaptives® Inc. Announces XcellaraHeart™, a Cardiovascular Wellness Formula Built on Xcellara’s Human-Clinical Data Demonstrating a 268.8% Increase in Circulating Stem/Progenitor-Type Cells
• Ian Rodger to Join Water Tower Research Fireside Chat on the McDermitt Lithium Project and Nasdaq Listing Plans on Thursday, July 16, 2026
• IANS Launches the First Cybersecurity MCP Server Delivering Practitioner-Validated Intelligence Directly into Clients' Native AI Tools